CLINICAL_TRIALS
trial_result
· 2022-04-04
Clinical Trial Update: CD24Fc for the Treatment of Immune Related Adverse Events in Patients With Advanced Solid Tumors, TIRAEC Study [Phase 1, Phase 2]
Summary
Clinical trial updates for CD24Fc (TIRAEC study) in advanced solid tumors show termination after Phase 1/2 with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tianhong Li | Conditions: Advanced Malignant Solid Neoplasm | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-04-04